Johnson & Johnson unit minimized risks of drug - report
Key points
- Janssen Pharmaceutica Products, a unit of Johnson & Johnson, notified doctors that it minimized the risks of a popular drug for schizophrenia in promotional materials, according to the Associated Press.
- Janssen sent a two-page letter to health care providers this week to clarify the risks of the drug, the report said, citing Janssen spokeswoman Carol Goodrich.
- Goodrich did not immediately return a phone message left by Reuters.
- Last year the Food and Drug Administration told several makers of antipsychotic drugs to update their product labels.
Janssen Pharmaceutica Products, a unit of Johnson & Johnson, notified doctors that it minimized the risks of a popular drug for schizophrenia in promotional materials, according to the Associated Press.
Janssen sent a two-page letter to health care providers this week to clarify the risks of the drug, the report said, citing Janssen spokeswoman Carol Goodrich.
Goodrich did not immediately return a phone message left by Reuters.
Last year the Food and Drug Administration told several makers of antipsychotic drugs to update their product labels.
The agency determined that Janssen's promotional material minimized the risk of strokes, diabetes, and other potentially fatal complications, according to the AP. The agency also said that Janssen had made misleading claims that the medication was safer than similar drugs.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Mental Health →
NewsPotential drug target for PTSD prevention
Scientists at Yerkes National Primate Research Center, Emory University have identified a drug that appears to make memories of fearsome events less durable in mice. The finding may accelerate the development of…
1 July 2014
NewsPrior drug use is the greatest predictor of ecstasy use US high school seniors
Ecstasy, also known by its chemical abbreviation MDMA, is an illicit drug that is commonly taken at nightclubs and dance parties. Ecstasy’s street names include: “Molly” (U.S.), “Mandy” (U.K.), “E,” and “X.” Although…
26 June 2014
NewsThe real risks of growing up with bipolar parents
Bipolar disorder (BD) is among the 10 most burdensome medical conditions, according to the World Health Organization. The disorder is known for its dramatic highs of extreme euphoria, racing thoughts and decreased need…
